Kaspi.kz remains a strong portfolio holding with a forward price-to-earnings ratio below 10 and promising growth prospects despite current revenue pressure from a strong Kazakhstani tenge. Lower National Bank interest rates are expected to improve Kaspi's profitability starting in Q4 by reducing funding costs and enhancing fintech earnings. Additionally, Kaspi's expansion into grocery stores, leveraging existing infrastructure, could increase revenues by up to 33% in the medium term, supported by a pilot project showing a 15% EBITDA margin. In Turkey, Hepsiburada's break-even status and reduced investments from 2027 signal potential future capital returns and profit growth, with expectations of more dividends and share buybacks.
Kaspi.kz is the subject of this update, and here is Pluang's Financials sector snapshot as of Nov 11, 2026 00:51 WIB: Among 142 priced Financials-sector US stocks, 67 rose and 72 fell today. Rocket Companies Inc. (RKT) traded at USD 14.43 with a 5.04% decline, SoFi Technologies Inc. (SOFI) at USD 15.96 fell 4.69% with 88% of Pluang orders selling, and XP Inc. (XP) at USD 14.78 dropped 4.46% with all Pluang orders selling. Typical hold times vary from 3 to 62 days across these movers.
As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...
EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...
The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...
Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...
Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...
